Science Explorer Interactive view Map
Company · Branford · United States

IsoPlexis (United States)

isoplexis.comROR OpenAlex
Research works
26
▲ 420% vs 2013–17
Citations
793
30.0 per fractional work
Top-10% rate
24.0%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: IsoPlexis (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.78× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 36.57× its world share, 3 worksImmunology and Micro…Neuroscience: 0.57× its world share, 0 worksNeuroscienceChemistry: 1.18× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.47× its world share, 0 worksEarth and Planetary …Engineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMedicine: 2.48× its world share, 4 worksMedicineBusiness, Management and Accounting: 1.72× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 36.6×. Every wedge is a field page.

Who are the top researchers at IsoPlexis (United States)?

Ranked on the composite score, Sean Mackay lead among researchers whose main affiliation is IsoPlexis (United States).

  1. 1 Sean Mackay United States · #471,838 worldwide 77 citations · 17 works
All ranked researchers at IsoPlexis (United States)

Which keywords describe research at IsoPlexis (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Immunity, Tumor Microenvironment and Immune Checkpoint Blockade.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cancer Immunotherapy8▲ 206×2 topics
  2. Immunotherapy6▲ 35×4 topics
  3. Tumor Regression6▲ 255×2 topics
  4. CAR T Cells6▲ 500×1 topic
  5. Chimeric Antigen Receptor6▲ 500×1 topic
  6. Immunity3▲ 33×4 topics
  7. Tumor Microenvironment2▲ 26×4 topics
  8. Immune Checkpoint Blockade2▲ 148×1 topic
  9. PD-1 and PD-L12▲ 148×1 topic
  10. Innate Immunity2▲ 21×2 topics
  11. Antigen Presentation2▲ 71×1 topic
  12. Dendritic Cells2▲ 62×1 topic
  13. Inflammation2▲ 2.4×7 topics
  14. Cancer1▲ 3.8×6 topics
  15. Gene Expression1▲ 8.8×3 topics
  16. NK Cell Recognition1▲ 52×1 topic
  17. Natural Killer Cells1▲ 52×1 topic
  18. Autoimmunity1▲ 24×2 topics
  19. Foxp31▲ 66×1 topic
  20. Monoclonal Antibodies1▲ 34×2 topics
  21. Single-Cell1▲ 235×1 topic
  22. TGF-ß1▲ 28×1 topic
  23. Transcriptomics1▲ 235×1 topic
  24. Biotechnology1▲ 39×1 topic
  25. Genetically Modified Crops1▲ 299×1 topic
  26. Glycosylation1▲ 17×3 topics

Which research topics does IsoPlexis (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, T-cell and B-cell Immunology and Immune Cell Function and Interaction.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksT-cell and B-cell Immuno…1T-cell and B-cell Immunology: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksBusiness Process Modeling and Analysis: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksImmune cells in cancer: 0 fractional worksInflammatory Biomarkers in Disease Prognosis: 0 fractional works
OncologyImmunologyManagement Information SystemsRadiology, Nuclear Medicine and Imaging

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Immunotherapy and Immune Responses Immunology 1 works
  3. 3 T-cell and B-cell Immunology Immunology 1 works
  4. 4 Immune Cell Function and Interaction Immunology 1 works
  5. 5 Business Process Modeling and Analysis Management Information Systems 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 0 works
  9. 9 Immune cells in cancer Immunology 0 works
  10. 10 Inflammatory Biomarkers in Disease Prognosis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.9%not open45.1%

World: 28% of research is openly available.

with international co-authors16.4%domestic only83.6%

World: 19% is written across borders.

How has IsoPlexis (United States)'s research output changed?

Output in 2018–2022 was 420% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Branford

All research institutions in Branford

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.